Ianwil
I'm very sorry to hear that. Your concerns go well beyond mine. What they're doing here, making an effective treatment available at a fair price, is a goal worth aiming for. Too often, the best treatments are reserved for the wealthy.
IMU is privy to data that hasn't come out in this announcement. The stuff I was really hoping for, the long term patient benefit, is still under wraps. It could be that there won't be any announcement until the 3rd cohort has had a lot more time. Some of those extra patients were recruited late in the day, so it could be some time. Meanwhile, the announcement feels frustratingly incomplete without some good and current news about the patients.
All the best.
Mer.
Ann: IMU Meets Endpoints in Phase 1b Gastric Cancer Trial, page-19
-
- There are more pages in this discussion • 99 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $386.7M | |||
| Open | High | Low | Value | Volume |
| 3.9¢ | 3.9¢ | 3.7¢ | $388.1K | 10.11M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 146314 | 3.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 2536521 | 6 |
View Market Depth
| Last trade - 16.10pm 02/12/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
